Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€44.00

€44.00

0.410%
0.19
0.410%
-
 
02.07.25 / Tradegate WKN: A117KY / Name: Trupanion / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

Trupanion Inc. Stock

Trupanion Inc. gained 0.410% compared to yesterday.
Our community identified positive and negative aspects for Trupanion Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Trupanion Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Trupanion Inc. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Trupanion Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Trupanion Inc. 0.410% -7.134% 7.790% 70.345% -6.799% -24.786% 15.183%
Surgery Partners Inc -2.630% 2.703% -5.941% -13.636% -4.040% -30.326% 93.878%
Orasure Tech 0.790% -1.563% 0.800% -36.041% -26.316% -1.563% -74.673%
Addus Homecare Corp. -1.560% -0.518% 0.524% -9.434% -20.000% 23.871% 15.663%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

When examining the financials of Trupanion, a notable player in the Healthcare Providers & Services sector, the overall impression is a blend of potential and challenges. The company showcases strong revenue generation, yet grapples with negative net income and declining profitability margins. In a competitive landscape, these financial metrics provide insights into areas of strength and concern, presenting both opportunities for improvement and steps necessary toward sustainability.

Incremental Revenue Growth: Trupanion reports a total revenue of approximately $1.16 billion for the trailing twelve months (TTM). This reflects a quarterly revenue growth of approximately 19.4% year-over-year. Despite the negative earnings, accelerating revenue growth signals a robust demand for its services, which might position the company favorably for future profitability.

Strong Market Capitalization: With a market capitalization of around $1.43 billion, Trupanion stands as a relatively substantial entity within its niche, suggesting investor confidence. A sturdy market cap enables the company to leverage capital markets better, facilitating opportunities for investment in growth initiatives.

Comments

News

Trupanion: A Solid Investment in the Growing Pet Insurance Market?
Trupanion: A Solid Investment in the Growing Pet Insurance Market?

In this episode of the Motley Fool Scoreboard, analysts evaluate Trupanion (NASDAQ: TRUP) and its potential as a pet insurance leader. With a solid track record and a growing market, is Trupanion a

Trupanion Posts Revenue Beat, EPS Miss
Trupanion Posts Revenue Beat, EPS Miss

Trupanion (NASDAQ:TRUP), a leader in pet medical insurance, released its Q4 2024 earnings on February 19, 2025. The company delivered mixed results, with earnings per share (EPS) at $0.04, missing